Estimation of the effect of neutropenia on rates of clinical bacteraemia in HIV-infected patients

Epidemiology and Infection

Volumn 120, Issue 1, 1998, Pages 71-80

  Caperna, J ^a   Barber, R E ^a   Toerner, J G ^a   Mathews, W C ^a  

^a UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTEREMIA; COHORT ANALYSIS; ESCHERICHIA COLI; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; NEUTROPENIA; NEUTROPHIL; NONHUMAN; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BACTEREMIA; BLOOD CELL COUNT; COHORT STUDIES; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; NEUTROPENIA; NEUTROPHILS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 0031934008     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S095026889700842X     Document Type: Article

References (28)

1. Bodey GP, Buckley M, Sathe YS, Freirich EJ. Quantitative relationships between circulating leukocytes and infection inpatients with acute leukemia. Ann Intern Med 1966; 64: 328-40.
2. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993; 328: 1328-32.
3. Weinberger M. Approach to management of fever and infection in patients with primary bone marrow failure and hemoglobinopathies. Hematol/Oncol Clin N Am 1993; 7: 865-85.
4. Pizzo PA. Evaluation of fever in the patient with cancer. Eur J Cancer Clin Oncol 1989; 25: S9-16.
5. Hardy WD. Combined ganciclovir and recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of cytomegalovirus retinitis in AIDS patients. J Acquir Immune Defic Syndr 1991; 4: S22-8.
6. Richman DD, Fischl MA, Grieco MH, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind placebo controlled trial. N Engl J. Med 1987; 317: 192-7.
7. Northfelt D, Hambleton J, Aragon T, Volberding P, Sande M, Kaplan L. Outcome of febrile neutropenia in patients with AIDS-related non-Hodgkin's lymphoma. Blood 1990; 76 Suppl 1: 491a.
8. Bogner JR, Kronawitter U, Rolinski, B, Truebenback K, Goebel FD. Liposomal doxorubicin in the treatment of advanced AIDS-related Kaposi sarcoma. J Acquir Immune Defic Syndr 1994; 7: 463-8.
9. Farber BF, Lesser M, Kaplan MH, Weltmann J, Napolitano B, Armellino D. Clinical significance of neutropenia in patients with human immunodeficiency virus infection. Infect Control Hosp Epidemiol 1991; 12: 429-34.
10. Piliero PJ, Currier JS, Barlam TF, Ives DV. Risk of bacteremia in HIV-infected person with neutropenia. In: Proceedings of the 2nd National Conference on Human Retroviruses and Related Infections, Volume 2. Washington: Infectious Disease Society of America, 1995: 78.
11. Shaunak S, Bartlett JA. Zidovudine-induced neutropenia: are we too cautious? Lancet 1989; ii: 91-2.
12. Hernandez-Quero J, Viciana P, Villanueva J, Vergara A, Giron JA, Lozano F. Fever plus neutropenia in AIDS patients: etiology and response to G-CSF. In: Proceedings of the X International Conference on AIDS, Tokyo: International AIDS Society, 1994: 188 (abstract no. PB0767).
13. Keiser P, Higgs E, Peterson D. Neutropenia is associated with bacterial infections. In: Proceedings of the X International Conference on AIDS. Tokyo: International AIDS Society, 1994: 140 (abstract no. PB0574).
14. Hambleton J, Aragon T, Modin G, Northfelt DW, Sande MA. Outcome for hospitalized patients with fever and neutropenia who are infected with the human immunodeficiency virus. Clin Infect Dis 1995; 20: 363-71.
15. Moore RD, Keruly JC, Chaisson RE. Neutropenia and bacterial infection in acquired immunodeficiency syndrome. Arch Intern Med 1995; 155: 1965-70.
16. Jacobson MA, Liu RC, Wong R, Rich W, Davies D, Cohen PT. HIV disease-related neutropenia and the risk of hospitalization for serious bacterial infection. In: Proceedings of the XI International Conference on AIDS, Volume 1. Vancouver: Xl International Conference on AIDS Society, 1996: 231 (abstract no. Tu. B. 180).
17. Keiser P, Higgs E, Smith. Neutropenia is associated with bacteremia in patients infected with the human immunodeficiency virus. Am J Med Sci 1996; 312: 118-22.
18. Pizzo PA. Granulocytopenia and cancer therapy: past problems, current solutions, future challenges. Cancer 1984; 54: 2649-61.
19. Clayton D, Hills M. Statistical models in epidemiology. New York: Oxford University Press, 1993: 197-204.
20. Ray WA, Griffin MR. Use of Medicaid data for pharmacoeopidemiology. Am J Epidemiol 1989; 129: 837-49.
21. Schimpff SC. Overview of empiric antibiotic therapy for the febrile neutropenic patient. Rev Infect Dis 1985; 7: S734-40.
22. Bates DW, Lee TH. Rapid classification of positive blood cultures: prospective validation of a multivariate algorithm. JAMA 1992; 267: 1962-6.
23. Leibovici L, Greenshtain S, Cohen O, Mor F, Wysenbeek AJ. Bacteremia in febrile patients: a clinical model for diagnosis. Arch Intern Med 1991; 151: 1801-6.
24. Yeheskelli Y, Subah S, Elhanan G, et al. Two rules for early prediction of bacteremia: testing in a university and a community hospital. J Gen Intern Med 1996; 11: 98-103.
25. Rothman KJ. Modern epidemiology. Boston/Toronto: Little, Brown, and Company, 1986; 66.
26. Babior BM, Golde DW. Production, distribution, and fate of neutrophils. In: Beutle E, Lichtman MA, Coller BS, Kipps TJ eds. Williams hematology, 5th ed. New York: McGraw-Hill, 1995; 775.
27. Chervenick, PA, Boggs DR, Marsh JC, Cartwright GE, Wintrobe MM. The blood and bone marrow neutrophil response to graded doses of endotoxin in mice. Proc Soc Exp Biol Med 1967; 126: 891-5.
28. Dale DC, Fauci AS, Guerry D, Wolff SM. Comparison of agents producing a neutrophil leukocytosis in man. J Clin Invest 1975; 56: 808-13.